Propolis can potentialise the anti-adhesion activity of proanthocyanidins on uropathogenic Escherichia coli in the prevention of recurrent urinary tract infections

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Lavigne, Jean Philippe ^a,b   Vitrac, Xavier ^c   Bernard, Louis ^d   Bruyère, Franck ^d   Sotto, Albert ^a  

^a INSERM   (France)

^b DEPARTMENT OF NEUROLOGY   (France)

^c Bordeaux Segalen University   (France)

^d UNIVERSITÉ DE TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); CAENORHABDITIS ELEGANS; ESCHERICHIA COLI; VACCINIUM MACROCARPON;

EID: 82255182399     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-522     Document Type: Article

References (31)

1. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Foxman B, Dis Mon 2003 49 53 70 10.1016/S0011-5029(03)90000-9 12601337 (Pubitemid 36350775)
2. Prevalence of hospital-acquired urinary tract infections in urology departments. Bjerklund Johansen TE, Cek M, Naber K, Strachounski L, Svendsen MV, Tenke P, PEP and PEAP study investigators, European Society of Infections in Urology, Eur Urol 2007 51 1100 1111 10.1016/j.eururo.2006.08.012 17049419 (Pubitemid 46281413)
3. The CTX-M -lactamase pandemic. Canton R, Coque TM, Curr Opin Microbiol 2006 9 466 475 10.1016/j.mib.2006.08.011 16942899 (Pubitemid 44397640)
4. Extended-spectrum -lactamase-producing Enterobacteriaceae in various types of private health care centers. Arpin C, Coulange L, Dubois V, André C, Fischer I, Fourmaux S, Grobost F, Jullin J, Dutilh B, Couture JF, Noury P, Lagrange I, Ducastaing A, Doermann HP, Quentin C, Antimicrob Agents Chemother 2007 51 3440 3444 10.1128/AAC.01431-06 17591853 (Pubitemid 350067575)
5. CTX-M -lactamase-producing Escherichia coli in French hospitals: prevalence, molecular epidemiology, and risk factors. Lavigne JP, Marchandin H, Delmas J, Moreau J, Bouziges N, Lecaillon E, Cavalie L, Jean-Pierre H, Bonnet R, Sotto A, J Clin Microbiol 2007 45 620 626 10.1128/JCM.01917-06 17108071
6. Community-wide outbreaks of clonally related CTX-M-14 beta-lactamase-producing Escherichia coli strains in the Calgary health region. Pitout JD, Gregson DB, Church DL, Elsayed S, Laupland KB, J Clin Microbiol 2005 43 2844 2849 10.1128/JCM.43.6.2844-2849.2005 15956407 (Pubitemid 40834300)
7. Treatment of bacterial urinary tract infections: presence and future. Wagenlehner FM, Naber KG, Eur Urol 2006 49 235 244 10.1016/j.eururo.2005.12.017 16413668 (Pubitemid 43197859)
8. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. Leflon-Guibout V, Blanco J, Amaqdouf K, Mora A, Guize L, Nicolas-Chanoine MH, J Clin Microbiol 2008 46 3900 3905 10.1128/JCM.00734-08 18842941
9. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Caniça MM, Park YJ, Lavigne JP, Pitout J, Johnson JR, J Antimicrob Chemother 2008 61 273 281 18077311
10. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Coque TM, Novais A, Carattoli A, Poirel L, Pitout J, Peixe L, Baquero F, Canton R, Nordmann P, Emerg Infect Dis 2008 14 195 200 10.3201/eid1402.070350 18258110 (Pubitemid 351213667)
11. Reduction of Escherichia coli adherence to uroepithelial bladder cells after consumption of cranberry juice: a double-blind randomized placebo-controlled cross-over trial. Di Martino P, Agniel R, David K, Templer C, Gaillard JL, Denys P, Botto H, World J Urol 2006 24 21 27 10.1007/s00345-005- 0045-z 16397814 (Pubitemid 43298679)
12. Cranberries for preventing urinary tract infections. Jepson RG, Craig JC, Cochrane Database of Syst Rev 2008 1 D001321
13. Role of cranberry juice on molecular-scale surface characteristics and adhesion behavior of Escherichia coli. Liu Y, Black MA, Caron L, Camesano TA, Biotechnol Bioeng 2006 93 297 305 10.1002/bit.20675 16142789
14. Inhibition of bacterial adherence by cranberry juice: potential use for the treatment of urinary tract infections. Sobota AE, J Urol 1984 131 1013 1016 6368872 (Pubitemid 14102683)
15. Inhibitory activity of cranberry juice on adherence of type I and type P fimbriated Escherichia coli to eucaryotic cells. Zafriri D, Ofek I, Adar R, Pocino M, Sharon N, Antimicrob Agents Chemother 1989 33 92 98 2653218 (Pubitemid 19015772)
16. Anti-Escherichia coli adhesin activity of cranberry and blueberry juices. Ofek I, Goldhar J, Zafriri D, Lis H, Adar R, Sharon N, N Engl J Med 1991 324 1599 2027368
17. In-vitro and in vivo evidence of dose-dependent decrease of uropathogenic Escherichia coli virulence after consumption of commercial Vaccinium macrocarpon (cranberry) capsules. Lavigne JP, Bourg G, Combescure C, Botto H, Sotto A, Clin Microbiol Infect 2008 14 350 355 10.1111/j.1469-0691.2007.01917.x 18190583 (Pubitemid 351356526)
18. Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surfaces. Beachey EH, J Infect Dis 1981 143 325 345 10.1093/infdis/143.3.325 7014727 (Pubitemid 11113653)
19. Inhibition of adherence of P-fimbriated Escherichia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries. Howell AB, Vorsa N, Der Marderosian A, Foo LY, N Engl J Med 1998 339 1085 1086 10.1056/NEJM199810083391516 9767006 (Pubitemid 28457878)
20. A-type proanthocyanidin trimers from cranberry that inhibit adherence of uropathogenic P-fimbriated Escherichia coli. Foo LY, Lu Y, Howell AB, Vorsa N, J Nat Prod 2000 63 1225 1228 10.1021/np000128u 11000024
21. Cranberry products inhibit adherence of uropathogenic Escherichia coli to primary cultured bladder and vaginal epithelial cells. Gupta K, Chou MY, Howell A, Wobbe C, Grady R, Stapleton AE, J Urol 2007 177 2357 2360 10.1016/j.juro.2007.01.114 17509358 (Pubitemid 46735945)
22. In vivo evidence that cranberry proanthocyanidins inhibit adherence of P-fimbriated E. coli bacteria to uroepithelial cells. Howell AB, Leahy MM, Kurowska E, Guthrie N, FASEB J 2001 15 284
23. Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study. Howell AB, Botto H, Combescure C, Blanc-Potard AB, Gausa L, Matsumoto T, Tenke P, Sotto A, Lavigne JP, BMC Infect Dis 2010 10 94 10.1186/1471-2334-10-94 20398248
24. Propolis: is there a potential for the development of new drugs? Sforcin JM, Bankova V, J Ethnopharmacol 2011 133 253 260 10.1016/j.jep.2010.10.032 20970490
25. Analysis of flavonoids from propolis by on-line HPLC-electrospray mass spectrometry. Volpi N, Bergonzini G, J Pharm Biomed Anal 2006 42 354 361 10.1016/j.jpba.2006.04.017 16762525 (Pubitemid 44310894)
26. The worm has turned - microbial virulence modeled in Caenorhabditis elegans. Sifri CD, Begun J, Ausubel FM, Trends Microbiol 2005 13 119 127 10.1016/j.tim.2005.01.003 15737730 (Pubitemid 40311894)
27. Caenorhabditis elegans as a simple model to study phenotypic and genetic virulence determinants of extraintestinal pathogenic Escherichia coli. Diard M, Baeriswyl S, Clermont O, Gouriou S, Picard B, Taddei F, Denamur E, Matic I, Microbes Infect 2007 9 214 223 10.1016/j.micinf.2006.11.009 17208486 (Pubitemid 46237749)
28. Bioactive compounds in cranberries and their role in prevention of urinary tract infections. Howell AB, Mol Nutr Food Res 2007 51 732 737 10.1002/mnfr.200700038 17487930 (Pubitemid 47083683)
29. Urinary excretion of anthocyanins in humans after cranberry juice ingestion. Ohnishi R, Ito H, Kasajima N, Kaneda M, Kariyama R, Kumon H, Hatano T, Yoshida T, Biotechnol Biochem 2006 70 1681 1687 10.1271/bbb.60023 (Pubitemid 44124927)
30. Reversing -lactam antibiotic resistance of Staphylococcus aureus with galangin from Alpinia officinarum Hance and synergism with ceftazidime. Eumkeba G, Sakdaratb S, Siriwonga S, Phytomed 2010 18 40 45 10.1016/j.phymed.2010.09.003
31. Phosphonate monolayers functionalized by silver thiolate species as antibacterial nanocoatings on titanium and stainless steel. Amalric J, Mutin PH, Guerrero G, Ponche A, Sotto A, Lavigne JP, J Mater Chem 2009 19 141 149 10.1039/b813344a